Table 2.
Maternal symptoms, biochemical markers, and adverse maternal outcome
| Adverse maternal outcome Present n (%) (n = 60) |
Adverse maternal outcome Absent n (%) (n = 262) |
OR (95 % CI) | P value | |
|---|---|---|---|---|
| Symptoms | ||||
| Headache (n = 62) | 17 (27.41) | 45 (72.58) | 1.91 (1.003–3.65) | 0.0489 |
| Visual disturbances (n = 29) | 11 (37.93) | 18 (62.06) | 3.05 (1.35–6.82) | 0.006 |
| Right upper quadrant or epigastric pain (n = 38) | 12 (31.57) | 26 (68.42) | 2.27 (1.07–4.82) | 0.03 |
| Chest pain or dyspnea (n = 40) | 18 (45.0) | 22 (54.0) | 4.69 (2.32–9.49) | <0.0001 |
| Biochemical markers | ||||
| Platelet count (<1.5 lacs) (n = 80) | 23 (28.75) | 57 (71.25) | 2.2 (1.23–4.06) | 0.0083 |
| AST (>40 U/l) (n = 122) | 31 (25.40) | 91 (74.6) | 2.0 (1.13–3.54) | 0.015 |
| Serum creatinine (>1.1 mg/dl) (n = 77) | 37 (48.05) | 40 (51.2) | 8.9 (4.8–16.5) | <0.0001 |
| Serum uric acid (>6 mg/dl) (n = 56) | 29 (51.8) | 27 (48.21) | 8.14 (4.2–15.57) | <0.0001 |
| Dipstick proteinuria (≥2) (n = 87) | 30 (34.48) | 57 (65.51) | 3.59 (2.0–6.4) | <0.0001 |